This holds also true for NK cell-derived NKExos, which besides the other advantages additionally express effector molecules like perforin/granzyme and FasL, per se enables killing of cancer cells exhibiting Fas receptors and being sensitive to apoptosis [26,27,28,29,30,31,32,38,72,73]. The gene discussed is PRF1; the disease is cancer.